REQUEST A DEMO
Total
USD $0.00
Search more companies

Suma Pharmaceuticals Private Limited (India)

Main Activities: Iron and Steel Mills and Ferroalloy Manufacturing
Full name: Suma Pharmaceuticals Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Suma Pharmaceuticals Private Limited is an unlisted company, incorporated on 06/08/1991. It has its registered office in the State of Maharashtra, India. Company's corporate identification number (CIN) is U27100MH1991PTC062830 and registration number is 062830. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
Plot No.126, Chikhloli, Midc New Bhendipada
Thane; Maharashtra; Postal Code: 421501

Contact Details: Purchase the Suma Pharmaceuticals Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Suma Pharmaceuticals Private Limited report to view the information.
Outstanding Shares:
Purchase the Suma Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Suma Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
August 06, 1991
Key Executives
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Company Performance
Financial values in the chart are available after Suma Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-31.16%
Total operating revenue
-31.83%
Operating profit (EBIT)
-25.89%
EBITDA
-11.14%
Net Profit (Loss) for the Period
-25.71%
Total assets
55.44%
Total equity
65.15%
Operating Profit Margin (ROS)
0.21%
Net Profit Margin
0.15%
Return on Equity (ROE)
-11.27%
Debt to Equity Ratio
113.69%
Quick Ratio
0.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?